Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer

Lee, JS; Yost, SE; Li, SM; Cui, YJ; Frankel, PH; Yuan, YC; Schmolze, D; Egelston, CA; Guo, WH; Murga, M; Chang, H; Bosserman, L; Yuan, Y

Yuan, Y (通讯作者),City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA.

CANCERS, 2022; 14 (13):

Abstract

Simple Summary The mechanisms of intrinsic and acquired resistance to CDK4/6 inhibitors are poorly understood. Patients with HR+ MBC treated with CDK4......

Full Text Link